These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7693154)

  • 21. 'COVER' (cover of vaccination evaluated rapidly): 23.
    Begg NT; Connellan TJ; Leon S
    Commun Dis Rep CDR Rev; 1992 Oct; 2(11):R132. PubMed ID: 1284934
    [No Abstract]   [Full Text] [Related]  

  • 22. 'COVER' (cover of vaccination evaluated rapidly): 17.
    Hardford SG; Begg NT
    CDR (Lond Engl Rev); 1991 Mar; 1(4):R38. PubMed ID: 1669770
    [No Abstract]   [Full Text] [Related]  

  • 23. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
    J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Considerations on the advisability of beginning the first immunization against diphtheria, tetanus, whooping cough and poliomyelitis in infants at the age of 3 months].
    MURANO G
    Nourrisson; 1960; 48():187-90. PubMed ID: 13726888
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVER (COVER of vaccination evaluated rapidly): 31.
    White JM; Leon S; Ramsay ME
    Commun Dis Rep CDR Rev; 1994 Oct; 4(11):R129-30. PubMed ID: 7787921
    [No Abstract]   [Full Text] [Related]  

  • 28. Update: childhood vaccine-preventable diseases--United States, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Oct; 43(39):718-20. PubMed ID: 8090160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Triple diphtheria-tetanus-whooping cough immunization in the first 3 months of life].
    POU DIAZ J
    Hisp Med; 1958 Aug; 15(170):391-8. PubMed ID: 13586717
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunization of infants with a triple adsorbed vaccine against diphtheria, tetanus and whooping cough].
    GIRARD O; NICOL L; CHEVE J; AMOUREUX G; ZOURBAS J; CARAES Y
    Ann Inst Pasteur (Paris); 1959 Apr; 96(4):491-5. PubMed ID: 13650292
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relation of type of vaccine & inoculation method to vaccination reactions after immunization against whooping cough diphtheria & tetauns].
    TASMAN A
    Ned Tijdschr Geneeskd; 1959 May; 103(20):1049-57. PubMed ID: 13666915
    [No Abstract]   [Full Text] [Related]  

  • 32. COVER/Körner 95-1 (April to June 1995). Vaccination coverage statistics for children up to 2 years old in the United Kingdom.
    White JM; Rush M; Leon S; Ramsay ME
    Commun Dis Rep CDR Rev; 1995 Nov; 5(12):R186-7. PubMed ID: 8541941
    [No Abstract]   [Full Text] [Related]  

  • 33. Pediatric combined formulation DTaP-IPV/Hib vaccine.
    White C; Halperin SA; Scheifele DW
    Expert Rev Vaccines; 2009 Jul; 8(7):831-40. PubMed ID: 19538110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 35. Haemophilus influenzae type b (Hib) vaccination and uptake predictors in Northern Ireland.
    Tohani VK; Boyle G; Moore T
    Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R52-4. PubMed ID: 8820195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diphtheria, whooping cough & tetanus vaccination in the child].
    LOIZAGA CA
    Dia Med; 1958 Feb; 30(7):180-1. PubMed ID: 13537775
    [No Abstract]   [Full Text] [Related]  

  • 37. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of the economic evaluation in the comparison of different vaccination programs against Haemophilus influenzae type b disease].
    de Campora E; Pizzuti R
    Ann Ig; 1995; 7(5):329-38. PubMed ID: 8679174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method.
    Ramsay ME; McVernon J; Andrews NJ; Heath PT; Slack MP
    J Infect Dis; 2003 Aug; 188(4):481-5. PubMed ID: 12898433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of protective vaccination in children with low and very low birth weight].
    Laskowska B
    Przegl Epidemiol; 1996; 50(4):431-3. PubMed ID: 9132802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.